Director/PDMR Shareholding
Clinigen Group
925.00p
16:39 04/04/22
13 June 2024
VIDENDUM PLC
Notification of Transactions of Directors and Persons Discharging Managerial Responsibility (PDMRs)
Grant of options under Sharesave Scheme
Videndum plc ("the Company") announces that on 12 June 2024 the following grant of options over ordinary shares of 20 pence each was made under Videndum plc's 2020 UK Sharesave Plan and 2020 International Sharesave Plan to Executive Directors and PDMRs.
Name | Position | Award of Sharesave Options | Option Price | Expected maturity date
|
Stephen Bird | Group Chief Executive | 2,865 | £2.24 | 1 August 2027 |
Andrea Rigamonti | Group Chief Financial Officer | 2,865 | £2.24 | 1 August 2027 |
Marco Vidali | PDMR | 1,143 | £2.38 | 1 August 2026 |
Nicola Dal Toso | PDMR | 2,751 | £2.24 | 1 August 2027 |
Enquiries:
Jon Bolton
Group Company Secretary
020 8332 4600
A snapshot of Videndum plc
Videndum is a leading global provider of premium branded hardware products and software solutions to the content creation market. We are organised in three Divisions: Videndum Media Solutions, Videndum Production Solutions and Videndum Creative Solutions.
Videndum's customers include broadcasters, film studios, production and rental companies, photographers, independent content creators ("ICC"), professional musicians and enterprises. Our product portfolio includes camera supports, video transmission systems and monitors, live streaming solutions, smartphone accessories, robotic camera systems, prompters, LED lighting, mobile power, carrying solutions, backgrounds, audio capture, and noise reduction equipment.
We employ around 1,600 people across the world in ten different countries. Videndum plc is listed on the London Stock Exchange, ticker: VID.
More information can be found at: https://videndum.com/
LEI number: 2138007H5DQ4X8YOCF14
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.